Allergen-induced bronchospasm in passively sensitized guinea pigs: influence of new substances in comparison to reference compounds.
Madi
S
S
Lehrstuhl für Pharmakologie, Martin-Luther-Universität, Halle-Wittenberg.
Giessler
J
J
Hirschelmann
R
R
Friedrich
G
G
Braquet
P
P
D000179:Acrylates / Q000627:therapeutic use; D000485:Allergens / Q000276:immunology*; D000818:Animals; D001381:Azepines / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use; D001986:Bronchial Spasm / Q000188:drug therapy* / Q000276:immunology; D004195:Disease Models, Animal; D006168:Guinea Pigs; D007116:Immunization, Passive; D008297:Male; D010047:Ovalbumin / Q000276:immunology; D010741:Phospholipases A / Q000037:antagonists & inhibitors; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors; D013777:Tetrazoles / Q000627:therapeutic use; D058924:Thienopyridines; D014230:Triazoles
D000179:Acrylates; D000485:Allergens; D001381:Azepines; D001565:Benzoates; D010972:Platelet Activating Factor; D013777:Tetrazoles; D058924:Thienopyridines; D014230:Triazoles; C066686:BN 50730; C069438:3-(4-octadecyl)benzoylacrylic acid; D010047:Ovalbumin; D010741:Phospholipases A